Labs / Assays & in vitro testing
BioAscent
Lanarkshire, United Kingdom · bioascent.com
BioAscent provides integrated drug discovery services for pharmaceutical and biotechnology projects. It is based in Newhouse, Scotland, UK, and supports clients with assay development, screening, chemistry, computational design, protein science, and compound management. The company also operates automated compound storage and logistics for customer libraries.
They take quote requests by email.
What they offer
Biochemical, Biophysical & Cellular Assay Development
Develops and validates assays for drug discovery programs across biochemical, biophysical, and cellular formats.
Target Analysis & Bespoke Screening Strategies
Designs and runs assay cascades to identify promising chemistry and triage screening liabilities.
Compound Screening
Runs compound screening, including high-throughput screening and fragment screening.
In Silico Discovery and AI
Applies computational chemistry, CADD, cheminformatics, and data analysis to support drug discovery projects.
Medicinal Chemistry
Designs and synthesizes compounds through hit generation, hit-to-lead, and lead optimization stages.
Synthetic Chemistry
Provides synthesis support for discovery chemistry programs.
Physicochemical Profiling & DMPK
Supports profiling related to physicochemical properties and DMPK in discovery projects.
Protein Production
Produces proteins for drug discovery work.
Surface Plasmon Resonance (SPR) & Biophysics
Uses SPR and biophysical methods to support interaction and binding studies.
Structural Biology
Supports structural biology work for drug discovery projects.
Compound Management
Stores, manages, reformats, and replicates compound libraries in liquid and solid formats.
External Library Selection & Sourcing
Selects and sources external libraries for screening and discovery campaigns.
What they work on
- Modalities
- Small molecule, Peptide, Recombinant protein
- Assays and studies
- biochemical assays, biophysical assays, cellular assays, high-throughput screening, fragment screening, assay cascade design, mechanistic profiling, molecular pharmacology, PAINS de-selection assays
- Instruments and platforms
- LC-MS, NMR, Mosaic from Titian, robotic systems, surface plasmon resonance (SPR)
- Scale and capacity
- over 1.5 million compounds managed for customers, libraries up to 250k in size, over 100,000 screening plates, 96-well plate formats, 384-well plate formats, 1536-well plate formats, three individually housed -20°C stores
- Therapeutic areas
- CNS drug discovery, GPCR drug discovery, mitochondrial biology, cancer, neurodegenerative diseases
- What to send
- compound libraries in liquid and solid formats
- Type
- CRO
- Serves
- global customers, partners
- Founded
- 2013
Similar labs. Novalix, Aurigene Pharmaceutical Services, MedChem Partners, Sai Life
Found in a contract services directory. Listing built from bioascent.com. Work here? Claim this listing.